NSECertificate under SEBI (Depositories and Participants) Regulations, 20188 Jul 2026 · 8 Jul 2026, 03:01 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS
✦ AI Summary
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended 30th June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
AAREYDRUGS_08072026150132_74_5__Final.pdf
View document text
MANUFACTURER OF
BULK DRUGS &
IMPORTERS OF
SOLVENTS & CHEMICALS
H.O: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 : (022) 23455543 Email: corporate@aareydrugs.com
REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE (02525) 271049 Email: info@aareydrugs.com
CIN:L99999MH1990PLC056538
Date:- 8th July, 2026
BSE Limited National Stock Exchange of India Limited
The Manager, Exchange Plaza
Corporate Service Department BandraKurla Complex,
P.J. Towers, Dalal Street, Bandra (E),
Mumbai- 400 001 Mumbai – 400051
Scrip Code: 524412 NSE Symbol: AAREYDRUGS
Sub: Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018
for quarter ended 30th June, 2026.
Dear Sir/Madam,
We herewith enclose a Certificate under Regulation 74 (5) of SEBI (Depositories and Participants)
Regulations, 2018 received from M/s. MUFG Intime India Private Limited, Registrar and Share
Transfer Agent of our Company for quarter ended 30thJune, 2026.
Please take on record of the same and oblige
Thanking You,
Yours faithfully,
For Aarey Drugs & Pharmaceuticals Limited
Nimit Ghatalia
Director
DIN: 07069841
Encl.: a/a
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 01-07-2026
The Compliance Officer/ Company Secretary
AAREY DRUGS & PHARMACEUTICALS LIMITED
E 34, MIDC
TARAPUR, BOISAR
DIST THANA
THANE
PINCODE : 401506
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that
securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services